NM_000527.5(LDLR):c.244T>G (p.Cys82Gly) AND Hypercholesterolemia, familial, 1

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Dec 16, 2016
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000237614.1

Allele description [Variation Report for NM_000527.5(LDLR):c.244T>G (p.Cys82Gly)]

NM_000527.5(LDLR):c.244T>G (p.Cys82Gly)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.244T>G (p.Cys82Gly)
HGVS:
  • NC_000019.10:g.11102717T>G
  • NG_009060.1:g.18337T>G
  • NM_000527.5:c.244T>GMANE SELECT
  • NM_001195798.2:c.244T>G
  • NM_001195799.2:c.190+2372T>G
  • NM_001195800.2:c.244T>G
  • NM_001195803.2:c.244T>G
  • NP_000518.1:p.Cys82Gly
  • NP_000518.1:p.Cys82Gly
  • NP_001182727.1:p.Cys82Gly
  • NP_001182729.1:p.Cys82Gly
  • NP_001182732.1:p.Cys82Gly
  • LRG_274t1:c.244T>G
  • LRG_274:g.18337T>G
  • LRG_274p1:p.Cys82Gly
  • NC_000019.9:g.11213393T>G
  • NM_000527.4:c.244T>G
  • c.244T>G
Protein change:
C82G
Links:
LDLR-LOVD, British Heart Foundation: LDLR_001652; dbSNP: rs879254447
NCBI 1000 Genomes Browser:
rs879254447
Molecular consequence:
  • NM_001195799.2:c.190+2372T>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000527.5:c.244T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.244T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.244T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.244T>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
3

Condition(s)

Name:
Hypercholesterolemia, familial, 1
Synonyms:
LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000294550LDLR-LOVD, British Heart Foundation
criteria provided, single submitter

(ACGS Guidelines, 2013)		Likely pathogenic
(Mar 25, 2016) 		germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV000503117Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix
criteria provided, single submitter

(ACMG Guidelines, 2015)		Likely pathogenic
(Dec 16, 2016) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes3not providednot provided2601not providedclinical testing, literature only

Citations

PubMed

Molecular spectrum of autosomal dominant hypercholesterolemia in France.

Marduel M, Carrié A, Sassolas A, Devillers M, Carreau V, Di Filippo M, Erlich D, Abifadel M, Marques-Pinheiro A, Munnich A, Junien C; French ADH Research Network., Boileau C, Varret M, Rabès JP.

Hum Mutat. 2010 Nov;31(11):E1811-24. doi: 10.1002/humu.21348.

PubMed [citation]
PMID:
20809525
PMCID:
PMC3152176

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From LDLR-LOVD, British Heart Foundation, SCV000294550.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

From Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix, SCV000503117.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (1)

Description

subjects mutated among 2600 FH index cases screened = 2/previously described in association with FH / Software predictions: Damaging

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes2600not providednot provided2not providednot providednot provided

Last Updated: Feb 14, 2024